← Back to Investors

Apollo Health Ventures

Longevity-focused venture capital fund investing in companies developing therapeutics that target the fundamental biology of aging. Pioneer in connecting traditional VC with decentralized science (DeSci) through partnerships with VitaDAO.

Location
Dusseldorf, Germany / Boston, USA
Founded
2015
AUM
$300M+
Investment Range
$5M - $25M
Portfolio Companies
15
Focus
biotech-focused
Fund Stages
seed, series-a, series-b

Portfolio Companies

NameLocationFoundedCategories
Therini BioBoston, Massachusetts, USA2022
therapeuticsbiotech+3
HAYA TherapeuticsLausanne, Switzerland2015
therapeuticsbiotech+3
Auron TherapeuticsNew York, New York, USA2019
biotechoncology+3
Booster TherapeuticsCopenhagen, Denmark2024
biotechtherapeutics+3
Aeovian Pharmaceuticals--
therapeuticsbiotech+1
Cleara BiotechUtrecht, Netherlands2017
therapeuticsbiotech+3
Samsara TherapeuticsOxford, United Kingdom2019
therapeuticsbiotech+3
Bloom ScienceSan Francisco, California, USA2019
biotechtherapeutics+4
Focal BiosciencesBoston, Massachusetts, USA2020
biotechtherapeutics+3
Refoxy PharmaBerlin, Germany2020
biotechtherapeutics+2
Scripta TherapeuticsBoston, Massachusetts, USA2023
biotechtherapeutics+2
Galilei BiosciencesBoston, Massachusetts, USA2021
biotechlongevity+3
Ochre BioOxford, United Kingdom & New York, USA2019
biotechliver-disease+2
ThymoFoxBerlin, Germany2020
biotechimmunology+3
YEARSBerlin, Germany2021
precision-medicinebiomarkers+3